[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "CDC comes up to date", "description": "UK\nhttps://coronavirus.data.gov.uk\n\nhttps://covid.joinzoe.com/data#levels-over-time\n\nCases, + 2,357 + 2,474 = 4,439,691\n\nDeaths, + 4 + 20 = 127,629\n\nDeaths, + 290 (7 days) = 151,533\n\nVaccinations\n\nhttps://coronavirus.data.gov.uk/details/vaccinations\n\nFirst dose, + 115,053 = 35,587,348 (67.6%)\n\nSecond dose, + 231,835 = 18,088,385 (34.3%)\n\nFrance\n\nhttps://www.aljazeera.com/news/2021/5/10/france-records-20-cases-of-indian-covid-19-variant\n\nIndia variant, 20 cases, 5 clusters\n\nOlivier Veran, Health Minister\n\nReopen bars and restaurants for outdoor service on May 19\n\nVaccinations\n\nOne dose, 17.8 million (26.6%)\n\nSecond dose, 7.8 million\n\nITU cases\n\nSaturday, 5,005\n\nSunday, 4,971\n\nFirst drop below, 5,000 since March 29\n\nUS\n\nhttps://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases\n\nhttps://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use\n\nU.S. Food and Drug Administration\n\nExpanded emergency use authorization\n\nPfizer-BioNTech COVID-19 Vaccine\n\n12 to 15 years of age\n\nJanet Woodcock, (FDA)\n\nallows for a younger population to be protected\n\nbringing us closer to returning to a sense of normalcy\n\nand to ending the pandemic\n\nMarch 1, 2020 through April 30, 2021\n\n1.5 million COVID-19 cases in individuals 11 to 17 years\n\nTwo doses, three weeks apart\n\nPotential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks\n\n\n \n\nScientific Brief: SARS-CoV-2 Transmission (7th May)\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/sars-cov-2-transmission.html\n\nhttps://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted\n\nSARS-CoV-2 is transmitted by exposure to infectious respiratory fluids\n\nPeople release respiratory fluids\n\nInfection depends on concentration of viral particles\n\nThree principal ways: \n\nInhalation\n\nMucous membranes depositions\n\nTouching mucous membranes\n\nFactors in inoculum\n\nAirstream \n\nThermal layering and \n\nInitial jetting of exhalations\n\nEnclosed spaces\n\nIncreased exhalation\n\nProlonged exposure\n\nProgressive loss of viral viability and infectiousness\n\nTemperature\n\nHumidity\n\nUltraviolet radiation \n\nInfection still possible\n\nMore than 6 feet away\n\nPassing through a space an infectious person has left\n\nPrevention of transmission\n\nPhysical distancing \n\nWell-fitting masks\n\nAdequate ventilation\n\nAvoidance of crowded indoor spaces\n\nhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00869-2/fulltext\n\n\nhttps://www.nytimes.com/2021/05/07/opinion/coronavirus-airborne-transmission.html\n\nHistory\n\nCDC, masks, 19th April 2020\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover-guidance.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprevent-getting-sick%2Fcloth-face-cover.html\n\nWHO, masks, 5th June 2020\n\nhttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks\n\nhttps://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---5-june-2020\n\nVaccine factors\n\nhttps://www.theguardian.com/world/live/2021/may/11/coronavirus-live-news-india-variant-of-concern-globally-says-who-pfizer-vaccine-approved-for-us-12-15-year-olds\n\nAstraZeneca, 20 manufacturing partners around the world\n\nWith which it has shared the Covid-19 vaccine technology\n\nIndia\u2019s Serum Institute, has supplied 300m doses so far to 165 countries\n\n90% of India\u2019s vaccines so far\n\nProviding 98% of the supply to Covax\n\nPledged not-for-profit basis for the duration\n\nAstraZeneca lost money first three months of the year\n\nPfizer and Moderna are on course to make $45bn (\u00a332bn) collectively from their coronavirus vaccines this year", "link": "https://www.youtube.com/watch?v=1PGGU4RYyAg", "date_published": "2021-05-12 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Ivermectin advised for India", "description": "WHO, India VOC, global concern\n\nhttps://www.who.int\n\nhttps://www.bbc.co.uk/news/world-asia-india-57067190\n\nSame status as UK, South Africa and Brazil\n\nSpreads more easily than other variants\n\nRequired more study\n\nMore than 30 countries\n\nMay be some evidence of reduced neutralization\n\nIndia\n\nLink between variant and second wave\n\nCases, + 366,161 \n\nDeaths, + 3,754\n\nAndhra Pradesh, 11 deaths overnight, oxygen tanker delayed\n\nUnder reported deaths\n\nhttps://www.dw.com/en/india-bodies-of-suspected-covid-19-victims-wash-up-on-ganges-riverbanks/a-57489467\n\nhttps://www.bbc.co.uk/news/world-asia-india-56969086\n\n11th April, Ahmedabad, 69 body bags, 20 deaths reported\n\n16th April, visited 21 cremation grounds, 200 bodies, 25deaths reported\n\n5th May, 500, 83\n\nGujarat, possibly x 10\n\n35 \u2013 40 bodies recovered from Ganges in Bihar, from Uttar Pradesh\n\nVaccination\n\nTwo doses, 34.8 million (2.5%)\n\nJoint Statement on Widespread Use of Ivermectin in India for Prevention and Early Treatment\n\nhttps://covid19criticalcare.com\n\nhttps://covid19criticalcare.com/videos-and-press/flccc-releases/joint-statement-may-03-2021-joint-statement-on-widespread-use-of-ivermectin-in-india-for-prevention-and-early-treatment\n\nThe Evidence-Based Medicine Consultancy\n\nFrontline Covid Critical Care Alliance\n\nBritish Ivermectin Recommendation Development (BiRD) panel\n\nRe-purposed existing drugs\n\nIvermectin, a safe medicine which has been used for nearly 40 years to treat parasitic infections\n\n3.7 billion people have been treated with Ivermectin for parasitic infections and it has been found to be extremely safe\n\nNew evidence shows that it has potent antiviral and anti-inflammatory properties as well\n\nurge the Indian Government and all states in India to adopt Ivermectin as a matter of urgency as a front line prophylaxis and treatment for Covid-19\n\nAll India Institute of Medical Sciences and Indian Council of Medical Research have urgently responded with a recommendation to use Ivermectin in mild outpatient illness\n\nWe also recommend that Ivermectin be used as covid-19 prophylaxis\n\non a large scale through mass distribution of Ivermectin in the dose of 0.2mg/kg (12mg for a 60 kg person) \n\nweekly to adults to decrease transmission amongst the general population in the current crisis\n\nWe believe this will save thousands of lives and reduces the suffering of millions. \n\nDr. Tess Lawrie, Dr Shashikanth Manikappa, Dr Pierre Kory\n\nMucormycosis\n\nhttps://www.cdc.gov/fungal/diseases/mucormycosis/index.html\n\nhttps://emedicine.medscape.com/article/222551-overview\n\nMucor mould \n\nTypically, 2 weeks after recovery\n\nStuffy and bleeding nose\n\nPeriorbital swelling and pain in the eye\n\nDrooping of eyelids\n\nBlurred vision leading to loss of vision\n\nBlack discharge from the nose\n\nPrevent\n\nManage diabetes\n\nCorrect use and monitoring of steroids\n\nManage blood sugar throughout treatment\n\nTreat\n\nAnti-fungal intravenous injection\n\n3,500 rupees ($48) a dose\n\nAdministered every day up to eight weeks\n\nDr Hegde, Bengaluru\n\nThe strain of the virus appears to be virulent, sending blood sugars soaring to very high levels. \n\nAnd strangely, the fungal infection is affecting a lot of young people\n\nNepal\n\nhttps://www.dw.com/en/covid-19-special-nepal-struggles-to-cope-as-cases-surge/av-57487346\n\nAirport closed\n\nMigrant workers return from India\n\nCases increased in border towns first\n\nAlready circulating in Kathmandu valley\n\nValley has remained an epicentre\n\nThen half a million left on same day\n\nPM advocated herbal cures\n\nPolitical rallies, religious festivals, massive weddings \n\n57 times more daily cases than last month\n\nPatients treated outside hospitals\n\nIndian COVID, Philippines\n\nhttps://www.dw.com/en/coronavirus-digest-indian-covid-variant-reaches-philippines/a-57490707\n\nReturning workers from UAE and Oman\n\nNigeria\nPopulation 200 million\nVaccine deliveries down\n4 million doses arrived so far\nJohnson & Johnson arriving later this year\nPoor compliance\nhttps://www.theguardian.com/world/live/2021/may/11/coronavirus-live-news-india-variant-of-concern-globally-says-who-pfizer-vaccine-approved-for-us-12-15-year-olds\nGovernment reimposed some lockdown restrictions\nVery limited testing, unreported numbers", "link": "https://www.youtube.com/watch?v=YyHkLfWLPFw", "date_published": "2021-05-11 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]